Crossmark

Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions

Published Online: 2025-05-30

Published Print: 2025-09

Authors

Ren, Shi-Yan

Zhang, Yi-Zhou
License Information

Text and Data Mining valid from 2025-05-30

Version of Record valid from 2025-05-30
More Information

Article History

Received: 23 February 2025

Accepted: 18 May 2025

First Online: 30 May 2025

Declarations

:

: The Authors have no conflicts of interest to disclose.

: This study was deemed exempt from Institutional Review Board review.

Document is current